Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595007 · ClinicalTrials.gov registry record
The Heroes Circle Opioid Project
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 28
- Enrollment target
NCT03595007: Completed study, sponsored by Wayne State University.
NCT03595007 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03595007 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this proposed pilot study is to extend the KKC Heroes Circle program to people with opioid use disorder (OUD) who are currently enrolled in methadone maintenance treatment (MMT) and who wish to learn these techniques to reduce their behavioral and physiological dependence on medication. The goal is to engage these MMT patients in a complementary (non-pharmacological) therapeutic activity that may improve their self-efficacy and personal control, reduce the impact of stressors and chronic pain, drug craving, affective and physical function, and lower reliance on pharmacological interventions.
Primary Outcome
Extracted from the patient's medical record
Interventions
- BEHAVIORAL Kids Kicking Cancer program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-11-30 |
What the finished NCT03595007 record still lists
NCT03595007 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Kids Kicking Cancer program is the first listed.
NCT03595007 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03595007 about?
NCT03595007 is a clinical study titled "The Heroes Circle Opioid Project". The purpose of this proposed pilot study is to extend the KKC Heroes Circle program to people with opioid use disorder (OUD) who are currently enrolled in methadone maintenance treatment (MMT) and who wish to learn these techniques to reduce their behavioral and physiological dependence on medicatio...
What is the current status of trial NCT03595007?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2018-08-01. Estimated completion is 2019-11-30.
What interventions are being tested in trial NCT03595007?
The interventions under investigation include: Kids Kicking Cancer program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03595007?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI